Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -110,000 | -64,000 | 42,000 | 52,000 | 15,000 |
| Other Working Capital | -417,000 | -104,000 | -6,000 | 138,000 | -420,000 |
| Other Operating Activity | 1,388,000 | 1,203,000 | 1,017,000 | 1,065,000 | 1,027,000 |
| Operating Cash Flow | $861,000 | $1,035,000 | $1,053,000 | $1,255,000 | $622,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -310,000 | -512,000 | -510,000 | -424,000 | -293,000 |
| Net Acquisitions | 0 | 0 | -3,000 | -9,000 | 0 |
| Purchase Of Investment | N/A | -87,000 | -444,000 | -59,000 | -12,000 |
| Sale Of Investment | N/A | 353,000 | 76,000 | 167,000 | 43,000 |
| Purchase Sale Intangibles | -33,000 | -242,000 | -71,000 | -29,000 | 95,000 |
| Other Investing Activity | 315,000 | -195,000 | 502,000 | 9,000 | 433,000 |
| Investing Cash Flow | $-30,000 | $-689,000 | $-451,000 | $-350,000 | $140,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 72,000 | -28,000 | -654,000 | -202,000 | -206,000 |
| Debt Issued | 666,000 | N/A | 0 | 0 | 0 |
| Debt Repayment | -110,000 | -27,000 | -320,000 | -100,000 | 0 |
| Dividend Paid | -284,000 | -52,000 | 868,000 | N/A | -284,000 |
| Other Financing Activity | -704,000 | 0 | -868,000 | 0 | -90,000 |
| Financing Cash Flow | $-360,000 | $-107,000 | $-974,000 | $-302,000 | $-580,000 |
| Exchange Rate Effect | -5,000 | -2,000 | -12,000 | 2,000 | -5,000 |
| Beginning Cash Position | 2,220,000 | 1,982,000 | 2,365,000 | 1,761,000 | 1,584,000 |
| End Cash Position | 2,685,000 | 2,220,000 | 1,982,000 | 2,365,000 | 1,761,000 |
| Net Cash Flow | $471,000 | $239,000 | $-372,000 | $603,000 | $182,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 861,000 | 1,035,000 | 1,053,000 | 1,255,000 | 622,000 |
| Capital Expenditure | -351,000 | -771,000 | -583,000 | -462,000 | -327,000 |
| Free Cash Flow | 510,000 | 264,000 | 470,000 | 793,000 | 295,000 |